Heart Health Center
Select a Health Center
Latest Headlines
FDA to Explore Possible Vytorin-Cancer Link
The FDA is investigating a report from the SEAS trial of a possible association between use of the drug Vytorin and increased cancer risk.
The FDA is investigating a report from the SEAS trial of a possible association between use of the drug Vytorin and increased cancer risk.



